Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 632 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

US FDA clears Teva Synribo injection

Teva Pharmaceutical Industries Global R&D president and chief scientific officer Michael Hayden said Teva has brought Synribo to the market for patients who need additional treatment options when

Watson introduces generic version of Actos

The company began the shipment of the product after winning the final FDA approval. Actos is a prescription medication indicated for type 2 diabetes used along with diet

Merck net sales down by 4% in Q3 2012

The firm’s GAAP net income for the third quarter declined to $1.79bn, down from $2.02bn for the same quarter in 2011. Merck’s pharmaceutical sales in the third quarter